A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease
β Scribed by A. Jennifer Morton; Mark J. Hunt; Angela K. Hodges; Paul D. Lewis; Amanda J. Redfern; Stephen B. Dunnett; Lesley Jones
- Book ID
- 109023785
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 617 KB
- Volume
- 21
- Category
- Article
- ISSN
- 0953-816X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Growth restriction, craniofacial dysmorphology, and central nervous system defects are the main diagnostic features of fetal alcohol syndrome. Studies in humans and mice have reported that the growth restriction can be prenatal or postnatal, but the underlying mechanisms remain unknown.
Background: A/JCr mice develop typhlitis in response to Helicobacter hepaticus infection, whereas C57BL/6 mice coexist with this bacterium in a "commensal" relationship and do not develop disease even during prolonged colonization. ## Methods: To determine mechanisms that control this balance bet
## Abstract ## Background Geneβdirected enzyme prodrug therapy (GDEPT) based on the __E. coli__ enzyme purine nucleoside phosphorylase (PNP) represents a new approach for treating slow growing tumours like prostate cancer (PCa). Expressed enzyme converts a systemically administered prodrug, fludar